7 Analysts Have This to Say About AVITA Medical
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on AVITA Medical (NASDAQ:RCEL) stock. The company has an average price target of $28.36 with a high of $40.00 and a low of $18.50. The average price target has increased by 10.48% over the past month.
July 28, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AVITA Medical (NASDAQ:RCEL) has received positive ratings from 7 analysts over the past 3 months, with an average price target of $28.36. The average price target has increased by 10.48% over the past month.
The positive ratings and increased price target from analysts indicate a bullish sentiment towards AVITA Medical. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100